Anthem Blue Cross Blue Shield PPO Plan - Teamworks at Home ...
Anthem Blue Cross Blue Shield PPO Plan - Teamworks at Home ...
Anthem Blue Cross Blue Shield PPO Plan - Teamworks at Home ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
General exclusions<br />
In addition to any other exclusions or limit<strong>at</strong>ions<br />
specifed in this chapter, the <strong>Plan</strong> does not cover<br />
the following:<br />
• Admission for diagnostic tests th<strong>at</strong> can be performed<br />
on an outp<strong>at</strong>ient basis�<br />
• Autopsies�<br />
• Blood pressure monitoring devices�<br />
• Charges for Christian Science care in a Christian<br />
Science san<strong>at</strong>orium, unless the confnement is for a<br />
condition th<strong>at</strong> would require a person of another faith<br />
to enter a hospital�<br />
• Charges for failure to keep scheduled visits�<br />
• Charges for or associ<strong>at</strong>ed with p<strong>at</strong>ient advocacy�<br />
• Charges for furnishing medical records or reports�<br />
• Charges for giving injections th<strong>at</strong> can be<br />
self-administered�<br />
• Charges for or rel<strong>at</strong>ed to care th<strong>at</strong> is custodial or not<br />
normally provided as preventive care or tre<strong>at</strong>ment of<br />
an illness� Custodial care includes giving medicine<br />
th<strong>at</strong> can usually be taken without help, preparing<br />
special foods, and helping you to walk, get in and out<br />
of bed, dress, e<strong>at</strong>, b<strong>at</strong>he, and use the toilet�<br />
• Charges for or rel<strong>at</strong>ed to care th<strong>at</strong> is investig<strong>at</strong>ive�<br />
A drug, device, diagnostic procedure, technology,<br />
or medical tre<strong>at</strong>ment or procedure is investig<strong>at</strong>ive<br />
if reliable evidence does not permit conclusions<br />
concerning its safety, efectiveness, or efect on health<br />
outcomes as compared with the standard means<br />
of tre<strong>at</strong>ment or diagnosis� <strong>Anthem</strong> BCBS bases a<br />
decision on an examin<strong>at</strong>ion of the following reliable<br />
evidence, none of which is determin<strong>at</strong>ive in and<br />
of itself:<br />
– Any drug, biologic device, diagnostic product,<br />
equipment, procedure, tre<strong>at</strong>ment, service, or<br />
supply used in or directly rel<strong>at</strong>ed to the diagnosis,<br />
evalu<strong>at</strong>ion, or tre<strong>at</strong>ment of a disease, injury, illness,<br />
or other health condition th<strong>at</strong> the administr<strong>at</strong>or<br />
or the administr<strong>at</strong>or’s designee determines in its<br />
sole discretion to be experimental or investig<strong>at</strong>ive�<br />
The administr<strong>at</strong>or will deem any drug, biologic<br />
device, diagnostic product, equipment, procedure,<br />
tre<strong>at</strong>ment, service, or supply to be experimental or<br />
investig<strong>at</strong>ive if the administr<strong>at</strong>or determines th<strong>at</strong><br />
one or more of the following criteria apply when<br />
the service is rendered with respect to the use<br />
for which benefts are sought� The drug, biologic<br />
device, diagnostic product, equipment, procedure,<br />
tre<strong>at</strong>ment, service, or supply:<br />
38<br />
° Cannot be legally marketed in the United St<strong>at</strong>es<br />
without the fnal approval of the Food and Drug<br />
Administr<strong>at</strong>ion (FDA), or other licensing or<br />
regul<strong>at</strong>ory agency, and such fnal approval has not<br />
been granted�<br />
° Has been determined by the FDA to be<br />
contraindic<strong>at</strong>ed for the specifc use�<br />
° Is provided as part of a clinical research protocol<br />
or clinical trial or is provided in any other manner<br />
th<strong>at</strong> is intended to evalu<strong>at</strong>e the safety, toxicity, or<br />
efcacy of the drug, biologic device, diagnostic<br />
product, equipment, procedure, tre<strong>at</strong>ment, service,<br />
or supply�<br />
° Is subject to review and approval of an<br />
Institutional Review Board (IRB) or other body<br />
serving a similar function�<br />
° Is provided pursuant to informed consent<br />
documents th<strong>at</strong> describe the drug, biologic<br />
device, diagnostic product, equipment, procedure,<br />
tre<strong>at</strong>ment, service, or supply as experimental<br />
or investig<strong>at</strong>ive, or otherwise indic<strong>at</strong>e th<strong>at</strong> the<br />
safety, toxicity, or efcacy of the drug, biologic<br />
device, diagnostic product, equipment, procedure,<br />
tre<strong>at</strong>ment, service, or supply is under evalu<strong>at</strong>ion�<br />
– Any service not deemed experimental or<br />
investig<strong>at</strong>ive based on the criteria above may still<br />
be deemed experimental or investig<strong>at</strong>ive by the<br />
administr<strong>at</strong>or� In determining whether a service<br />
is experimental or investig<strong>at</strong>ive, the administr<strong>at</strong>or<br />
will consider the inform<strong>at</strong>ion described below and<br />
assess whether:<br />
° The scientifc evidence is conclusory concerning<br />
the efect of the service on health outcomes�<br />
° The evidence demonstr<strong>at</strong>es th<strong>at</strong> the service<br />
improves net health outcomes of the total<br />
popul<strong>at</strong>ion for whom the service might be<br />
proposed by producing benefcial efects th<strong>at</strong><br />
outweigh any harmful efects�<br />
° The evidence demonstr<strong>at</strong>es th<strong>at</strong> the service<br />
has been shown to be benefcial for the total<br />
popul<strong>at</strong>ion for whom the service might be<br />
proposed as any established altern<strong>at</strong>ives and<br />
the evidence demonstr<strong>at</strong>es the service has been<br />
shown to improve the net health outcomes of the<br />
total popul<strong>at</strong>ion for whom the service might be<br />
proposed under the usual conditions of medical<br />
practice outside clinical investig<strong>at</strong>ory settings�<br />
– The inform<strong>at</strong>ion considered or evalu<strong>at</strong>ed by the<br />
administr<strong>at</strong>or to determine whether a drug, biologic<br />
device, diagnostic product, equipment, procedure,<br />
tre<strong>at</strong>ment, service, or supply is experimental or<br />
<strong>Anthem</strong> <strong>Blue</strong> <strong>Cross</strong> <strong>Blue</strong> <strong>Shield</strong> <strong>PPO</strong> <strong>Plan</strong>